My NCBISign In
Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients
Stefano Calza, Per Hall, Gert Auer, Judith Bjöhle, Sigrid Klaar, Ulrike Kronenwett, Edison T Liu, Lance Miller, Alexander Ploner, Johanna Smeds, Jonas Bergh, Yudi Pawitan
Breast Cancer Res. 2006; 8(4): R34. Published online 2006 July 17. doi: 10.1186/bcr1517
PMCID:
PMC1779468
Abstract Full Text PDF–237K Supplementary Material

Is Cited by the Following 36 Articles in this Archive:

A Three-Gene Model to Robustly Identify Breast Cancer Molecular Subtypes
Benjamin Haibe-Kains, Christine Desmedt, Sherene Loi, Aedin C. Culhane, Gianluca Bontempi, John Quackenbush, Christos Sotiriou
J Natl Cancer Inst. 2012 February 22; 104(4): 311–325. Published online 2012 January 18. doi: 10.1093/jnci/djr545
PMCID:
PMC3283537
Free in PMC on 2013/02/22
Basal Breast Cancer: A Complex and Deadly Molecular Subtype
F Bertucci, P Finetti, D Birnbaum
Curr Mol Med. 2012 January; 12(1): 96–110. Published online 2012 January. doi: 10.2174/156652412798376134
PMCID:
PMC3343384
Abstract Full Text PDF–871K
Novel Staging System for Predicting Disease-Specific Survival in Patients With Breast Cancer Treated With Surgery As the First Intervention: Time to Modify the Current American Joint Committee on Cancer Staging System
Min Yi, Elizabeth A. Mittendorf, Janice N. Cormier, Thomas A. Buchholz, Karl Bilimoria, Aysegul A. Sahin, Gabriel N. Hortobagyi, Ana Maria Gonzalez-Angulo, Sheng Luo, Aman U. Buzdar, Jaime R. Crow, Henry M. Kuerer, Kelly K. Hunt
J Clin Oncol. 2011 December 10; 29(35): 4654–4661. Published online 2011 November 14. doi: 10.1200/JCO.2011.38.3174
PMCID:
PMC3236648
Free in PMC on 2012/12/10
Prediction of Response to Neoadjuvant Chemotherapy: New Biomarker Approaches and Concepts
Carsten Denkert, Bruno Valentin Sinn, Yasmin Issa, Berit Maria Müller, Andrea Maisch, Michael Untch, Gunter von Minckwitz, Sibylle Loibl
Breast Care (Basel) 2011 August; 6(4): 265–272. Published online 2011 August 29. doi: 10.1159/000331696
PMCID:
PMC3225210
Free in PMC on 2012/08/01
Triple-Negative Breast Cancer: Clinical and Histological Correlations
Zeinab Elsawaf, Hans-Peter Sinn
Breast Care (Basel) 2011 August; 6(4): 273–278. Published online 2011 August 26. doi: 10.1159/000331643
PMCID:
PMC3225211
Free in PMC on 2012/08/01
Triple-negative breast cancers: an updated review on treatment options
K.B. Reddy
Curr Oncol. 2011 August; 18(4): e173–e179.
PMCID:
PMC3149549
Abstract Full Text PDF–477K
Management Options in Triple-Negative Breast Cancer
Christina A. Minami, Debra U. Chung, Helena R. Chang
Breast Cancer (Auckl) 2011; 5: 175–199. Published online 2011 July 27. doi: 10.4137/BCBCR.S6562
PMCID:
PMC3153117
Abstract Full Text PDF–650K
The Changing Role of Pathology in Breast Cancer Diagnosis and Treatment
Anthony S.-Y. Leong, Zhengping Zhuang
Pathobiology. 2011 June; 78(2): 99–114. doi: 10.1159/000292644
PMCID:
PMC3128144
Free in PMC on 2012/06/01
Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization
Kuo-Jang Kao, Kai-Ming Chang, Hui-Chi Hsu, Andrew T Huang
BMC Cancer. 2011; 11: 143. Published online 2011 April 18. doi: 10.1186/1471-2407-11-143
PMCID:
PMC3094326
Abstract Full Text PDF–8.6M Supplementary Material
Enhanced Anticancer Effect of the Combination of Cisplatin and TRAIL in Triple-Negative Breast Tumor cells
Liping Xu, Shuping Yin, Kaladhar B Reddy
Mol Cancer Ther. Author manuscript; available in PMC 2012 March 1.
Published in final edited form as: Mol Cancer Ther. 2011 March; 10(3): 550–557. Published online 2011 January 20. doi: 10.1158/1535-7163.MCT-10-0571
PMCID:
PMC3053434
Abstract Full Text PDF–1.2M
Clustering gene expression data with a penalized graph-based metric
Ariel E Bayá, Pablo M Granitto
BMC Bioinformatics. 2011; 12: 2. Published online 2011 January 4. doi: 10.1186/1471-2105-12-2
PMCID:
PMC3023695
Abstract Full Text PDF–663K Supplementary Material
Triple negative breast cancer: unmet medical needs
Sumanta Kumar Pal, Barrett H. Childs, Mark Pegram
Breast Cancer Res Treat. Author manuscript; available in PMC 2012 February 1.
Published in final edited form as: Breast Cancer Res Treat. 2011 February; 125(3): 627–636. Published online 2010 December 15. doi: 10.1007/s10549-010-1293-1
PMCID:
PMC3244802
Abstract Full Text PDF–875K Supplementary Material
Clinicopathlogic and Immunohistochemical Characteristics of Triple Negative Invasive Lobular Carcinoma
Ja Seung Koo, WooHee Jung
Yonsei Med J. 2011 January 1; 52(1): 89–97. Published online 2010 November 30. doi: 10.3349/ymj.2011.52.1.89
PMCID:
PMC3017713
Abstract Full Text PDF–549K
Targeting DNA Replication before it Starts: Cdc7 as a Therapeutic Target in p53-Mutant Breast Cancers
Sara Rodriguez-Acebes, Ian Proctor, Marco Loddo, Alex Wollenschlaeger, Mohammed Rashid, Mary Falzon, A. Toby Prevost, Richard Sainsbury, Kai Stoeber, Gareth H. Williams
Am J Pathol. 2010 October; 177(4): 2034–2045. doi: 10.2353/ajpath.2010.100421
PMCID:
PMC2947297
Abstract Full Text PDF–1.5M Supplementary Material
Minireview: Basal-Like Breast Cancer: From Molecular Profiles to Targeted Therapies
Daniel J. Toft, Vincent L. Cryns
Mol Endocrinol. 2011 February; 25(2): 199–211. Published online 2010 September 22. doi: 10.1210/me.2010-0164
PMCID:
PMC3035993
Abstract Full Text
A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor positive breast cancer
Torsten O. Nielsen, Joel S Parker, Samuel Leung, David Voduc, Mark Ebbert, Tammi Vickery, Sherri R. Davies, Jacqueline Snider, Inge J. Stijleman, Jerry Reed, Maggie C.U. Cheang, Elaine R. Mardis, Charles M. Perou, Philip S. Bernard, Matthew J. Ellis
Clin Cancer Res. Author manuscript; available in PMC 2011 November 1.
Published in final edited form as: Clin Cancer Res. 2010 November 1; 16(21): 5222–5232. Published online 2010 September 13. doi: 10.1158/1078-0432.CCR-10-1282
PMCID:
PMC2970720
Abstract Full Text PDF–1015K Supplementary Material
Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models
Siver A Moestue, Eldrid Borgan, Else M Huuse, Evita M Lindholm, Beathe Sitter, Anne-Lise Børresen-Dale, Olav Engebraaten, Gunhild M Mælandsmo, Ingrid S Gribbestad
BMC Cancer. 2010; 10: 433. Published online 2010 August 17. doi: 10.1186/1471-2407-10-433
PMCID:
PMC2931488
Abstract Full Text PDF–1.8M Supplementary Material
New advances on critical implications of tumor- and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrence
M. Mimeault, S.K. Batra
Histol Histopathol. Author manuscript; available in PMC 2010 December 6.
Published in final edited form as: Histol Histopathol. 2010 August; 25(8): 1057–1073.
PMCID:
PMC2997575
Abstract Full Text PDF–473K
The Embryonic Transcription Cofactor LBH Is a Direct Target of the Wnt Signaling Pathway in Epithelial Development and in Aggressive Basal Subtype Breast Cancers
Megan E. Rieger, Andrew H. Sims, Ebony R. Coats, Robert B. Clarke, Karoline J. Briegel
Mol Cell Biol. 2010 September; 30(17): 4267–4279. Published online 2010 July 6. doi: 10.1128/MCB.01418-09
PMCID:
PMC2937547
Abstract Full Text PDF–2.6M Supplementary Material
Expression signatures of TP53 mutations in serous ovarian cancers
Marcus Q Bernardini, Tsukasa Baba, Paula S Lee, Jason C Barnett, Gregory P Sfakianos, Angeles Alvarez Secord, Susan K Murphy, Edwin Iversen, Jeffrey R Marks, Andrew Berchuck
BMC Cancer. 2010; 10: 237. Published online 2010 May 26. doi: 10.1186/1471-2407-10-237
PMCID:
PMC2893110
Abstract Full Text PDF–1.7M Supplementary Material
Tracing the Tumor Lineage
Nicholas E. Navin, James Hicks
Mol Oncol. Author manuscript; available in PMC 2011 June 1.
Published in final edited form as: Mol Oncol. 2010 June; 4(3): 267–283. Published online 2010 May 5. doi: 10.1016/j.molonc.2010.04.010
PMCID:
PMC2904844
Abstract Full Text PDF–2.6M
Basal keratin expression in breast cancer by quantification of mRNA and by immunohistochemistry
Radzislaw Kordek, Piotr Potemski, Renata Kusinska, Elzbieta Pluciennik, Andrzej Bednarek
J Exp Clin Cancer Res. 2010; 29(1): 39. Published online 2010 April 28. doi: 10.1186/1756-9966-29-39
PMCID:
PMC2873424
Abstract Full Text PDF–548K
Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile
K Graham, A de las Morenas, A Tripathi, C King, M Kavanah, J Mendez, M Stone, J Slama, M Miller, G Antoine, H Willers, P Sebastiani, C L Rosenberg
Br J Cancer. 2010 April 13; 102(8): 1284–1293. Published online 2010 March 2. doi: 10.1038/sj.bjc.6605576
PMCID:
PMC2855998
Abstract Full Text PDF–1.0M Supplementary Material
A fuzzy gene expression-based computational approach improves breast cancer prognostication
Benjamin Haibe-Kains, Christine Desmedt, Françoise Rothé, Martine Piccart, Christos Sotiriou, Gianluca Bontempi
Genome Biol. 2010; 11(2): R18. Published online 2010 February 15. doi: 10.1186/gb-2010-11-2-r18
PMCID:
PMC2872878
Abstract Full Text PDF–1.4M Supplementary Material
Can Survival Prediction Be Improved By Merging Gene Expression Data Sets?
Haleh Yasrebi, Peter Sperisen, Viviane Praz, Philipp Bucher
PLoS One. 2009; 4(10): e7431. Published online 2009 October 23. doi: 10.1371/journal.pone.0007431
PMCID:
PMC2761544
Abstract Full Text PDF–645K Supplementary Material
Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy
Silvia Darb-Esfahani, Sibylle Loibl, Berit M Müller, Marc Roller, Carsten Denkert, Martina Komor, Karsten Schlüns, Jens Uwe Blohmer, Jan Budczies, Bernd Gerber, Aurelia Noske, Andreas du Bois, Wilko Weichert, Christian Jackisch, Manfred Dietel, Klaus Richter, Manfred Kaufmann, Gunter von Minckwitz
Breast Cancer Res. 2009; 11(5): R69. Published online 2009 September 16. doi: 10.1186/bcr2363
PMCID:
PMC2790846
Abstract Full Text PDF–795K Supplementary Material
A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progression
Min Yu, Gromoslaw A. Smolen, Jianmin Zhang, Ben Wittner, Benjamin J. Schott, Elena Brachtel, Sridhar Ramaswamy, Shyamala Maheswaran, Daniel A. Haber
Genes Dev. 2009 August 1; 23(15): 1737–1742. doi: 10.1101/gad.1809309
PMCID:
PMC2720264
Abstract Full Text PDF–608K
RCP is a human breast cancer–promoting gene with Ras-activating function
Jinqiu Zhang, Xuejing Liu, Arpita Datta, Kunde Govindarajan, Wai Leong Tam, Jianyong Han, Joshy George, Christopher Wong, Kalpana Ramnarayanan, Tze Yoong Phua, Wan Yee Leong, Yang Sun Chan, Nallasivam Palanisamy, Edison Tak-Bun Liu, Krishna Murthy Karuturi, Bing Lim, Lance David Miller
J Clin Invest. 2009 August 3; 119(8): 2171–2183. Published online 2009 July 20. doi: 10.1172/JCI37622
PMCID:
PMC2719918
Abstract Full Text PDF–4.5M Supplementary Material
A compact VEGF signature associated with distant metastases and poor outcomes
Zhiyuan Hu, Cheng Fan, Chad Livasy, Xiaping He, Daniel S Oh, Matthew G Ewend, Lisa A Carey, Subbaya Subramanian, Robert West, Francis Ikpatt, Olufunmilayo I Olopade, Matt van de Rijn, Charles M Perou
BMC Med. 2009; 7: 9. Published online 2009 March 16. doi: 10.1186/1741-7015-7-9
PMCID:
PMC2671523
Abstract Full Text PDF–1.7M Supplementary Material
Gene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancer
Mads Thomassen, Qihua Tan, Torben A Kruse
BMC Cancer. 2008; 8: 394. Published online 2008 December 30. doi: 10.1186/1471-2407-8-394
PMCID:
PMC2642844
Abstract Full Text PDF–279K
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk